glp-1 litigation news Lipsitz, Ponterio & Comerford Ozempic Lawsuit – July 2026

We know how difficult battling medical conditions can be, so we have made it easier to schedule a consultation via phone call

These share common characteristics: moderate fat content, easy digestibility, and relatively bland flavor profiles

Plus-size influencers have lamented publicly about how marketing agencies, telehealth companies and med spas will reach out to them seeking partnerships or wanting to pay them to promote the drugs

Rybelsus is licensed in the UK only for treating type 2 diabetes mellitus, not for weight loss

According to UVA Health, loss of muscle mass can have a negative impact on patients long-term metabolic health, frailty and overall longevity